AU2001268303A1 - Hepatitis c protease exosite for inhibitor design - Google Patents
Hepatitis c protease exosite for inhibitor designInfo
- Publication number
- AU2001268303A1 AU2001268303A1 AU2001268303A AU6830301A AU2001268303A1 AU 2001268303 A1 AU2001268303 A1 AU 2001268303A1 AU 2001268303 A AU2001268303 A AU 2001268303A AU 6830301 A AU6830301 A AU 6830301A AU 2001268303 A1 AU2001268303 A1 AU 2001268303A1
- Authority
- AU
- Australia
- Prior art keywords
- exosite
- hepatitis
- protease
- inhibitor design
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21090000P | 2000-06-11 | 2000-06-11 | |
| US60/210,900 | 2000-06-11 | ||
| PCT/US2001/018751 WO2001096540A2 (en) | 2000-06-11 | 2001-06-08 | Hepatitis c protease exosite for inhibitor design |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268303A1 true AU2001268303A1 (en) | 2001-12-24 |
Family
ID=22784757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268303A Abandoned AU2001268303A1 (en) | 2000-06-11 | 2001-06-08 | Hepatitis c protease exosite for inhibitor design |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020102533A1 (en) |
| AU (1) | AU2001268303A1 (en) |
| WO (1) | WO2001096540A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI357901B (en) | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
| PL2298766T3 (en) | 2005-03-03 | 2014-09-30 | H Lundbeck As | Pharmaceutical formulations comrpising a substituted pyridine derivative |
| US10590067B2 (en) | 2018-02-20 | 2020-03-17 | H. Lundbeck A/S | Alcohol derivatives of carboxamides as Kv7 potassium channel openers |
| EP3755684B1 (en) | 2018-02-20 | 2023-07-12 | H. Lundbeck A/S | Alcohol derivatives as kv7 potassium channel openers |
| EP4007571B1 (en) | 2019-08-02 | 2025-06-18 | H. Lundbeck A/S | Alcohol derivatives as kv7 potassium channel openers for use in epilepsy or seizures |
| JOP20220017A1 (en) | 2019-08-02 | 2023-01-30 | H Lundbeck As | Alcohol derivatives in the form of Kv7 potassium channel opening agents |
| AR119521A1 (en) | 2019-08-02 | 2021-12-22 | H Lundbeck As | ALCOHOL DERIVATIVES AS Kv7 POTASSIUM CHANNEL OPENERS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7679491A (en) * | 1990-04-04 | 1991-10-30 | Protos, Inc. | Hepatitis c virus protease inhibitors |
-
2001
- 2001-06-08 AU AU2001268303A patent/AU2001268303A1/en not_active Abandoned
- 2001-06-08 WO PCT/US2001/018751 patent/WO2001096540A2/en not_active Ceased
- 2001-06-11 US US09/878,579 patent/US20020102533A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001096540A2 (en) | 2001-12-20 |
| US20020102533A1 (en) | 2002-08-01 |
| WO2001096540A3 (en) | 2003-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001271427A1 (en) | Novel proteases | |
| AU2001249395A1 (en) | Isolated instructions for isolated execution | |
| EP1307203A4 (en) | Protease inhibitors | |
| AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
| AU2108601A (en) | Salicylamides as serine protease inhibitors | |
| AU2001285750A1 (en) | Urokinase inhibitors | |
| AU2001270792A1 (en) | Surfactant | |
| AU2002221057A1 (en) | Detergent | |
| IL153421A0 (en) | Protease inhibitors | |
| AU2001268303A1 (en) | Hepatitis c protease exosite for inhibitor design | |
| IL151087A0 (en) | Protease inhibitors | |
| AU1474801A (en) | Protease inhibitors | |
| AU1474601A (en) | Protease inhibitors | |
| AU4066900A (en) | Protease inhibitors | |
| AU3888200A (en) | Protease inhibitors | |
| AU2001294080A1 (en) | Pallet | |
| IL155997A0 (en) | Protease inhibitors | |
| AU6407701A (en) | Serine protease inhibitors | |
| IL155573A0 (en) | Novel compounds for use as hiv protease inhibitors | |
| AU2002218172A1 (en) | Detergent | |
| AUPQ852400A0 (en) | Pallet | |
| AU5709500A (en) | Serine protease inhibitor | |
| AU2001234146A1 (en) | Method for inhibiting trypsin-type serine proteases | |
| AU2001244658A1 (en) | Gamma-secretase-like protease inhibitors | |
| HK1057163A (en) | Protease inhibitors |